According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$32.98 Million a decrease over its 2022 earnings that were of -C$30.19 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.